Free Trial

GoviEx Uranium (CVE:GXU) Stock Price Up 16.7% - What's Next?

GoviEx Uranium logo with Energy background

GoviEx Uranium Inc. (CVE:GXU - Get Free Report) shot up 16.7% on Monday . The company traded as high as C$0.07 and last traded at C$0.07. 942,213 shares were traded during mid-day trading, an increase of 1% from the average session volume of 933,853 shares. The stock had previously closed at C$0.06.

GoviEx Uranium Price Performance

The stock has a market cap of C$56.89 million, a price-to-earnings ratio of -0.50 and a beta of 1.50. The company's 50-day moving average is C$0.06 and its 200-day moving average is C$0.06. The company has a quick ratio of 0.62, a current ratio of 3.16 and a debt-to-equity ratio of 0.40.

About GoviEx Uranium

(Get Free Report)

GoviEx Uranium Inc, a mineral resources company, engages in the acquisition, exploration, and development of uranium properties in Africa. The company's principal asset is the Madaouela project which holds 80% interest located in north-central Niger. It also owns 100% interest in the Muntanga project that consists of 3 mining licenses situated to the south of Lusaka, Zambia; and the Falea project, which consists of three exploration licenses located in Mali.

Featured Stories

Should You Invest $1,000 in GoviEx Uranium Right Now?

Before you consider GoviEx Uranium, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoviEx Uranium wasn't on the list.

While GoviEx Uranium currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines